Want to see INSM full AI Analyst Report?
Total Valuation
Insmed has a market cap or net worth of $24.70B. The enterprise value is $24.58B.
Market Cap$24.70B
Enterprise Value$24.58B
Share Statistics
Insmed has 218,381,500 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding218,381,500
Owned by Insiders0.71%
Owned by Institutions1.57%
Financial Efficiency
Insmed’s return on equity (ROE) is -1.73 and return on invested capital (ROIC) is -64.84%.
Return on Equity (ROE)-1.73
Return on Assets (ROA)-0.56
Return on Invested Capital (ROIC)-64.84%
Return on Capital Employed (ROCE)-0.66
Revenue Per Employee364.44K
Profits Per Employee-767.29K
Employee Count1,664
Asset Turnover0.27
Inventory Turnover0.95
Valuation Ratios
The current PE Ratio of Insmed is ―. Insmed’s PEG ratio is -1.80.
PE Ratio―
PS Ratio61.31
PB Ratio50.31
Price to FCF-38.43
Price to Operating Cash Flow-41.35
PEG Ratio-1.80
Income Statement
In the last 12 months, Insmed had revenue of 606.42M and earned -1.28B in profits. Earnings per share was -6.41.
Revenue606.42M
Gross Profit481.55M
Operating Income-1.18B
Pretax Income-1.27B
Net Income-1.28B
EBITDA-1.17B
Earnings Per Share (EPS)-6.41
Cash Flow
In the last 12 months, operating cash flow was -595.62M and capital expenditures -61.95M, giving a free cash flow of -657.58M billion.
Operating Cash Flow-595.62M
Free Cash Flow-657.58M
Free Cash Flow per Share-3.01
Dividends & Yields
Insmed pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.86
52-Week Price Change-40.62%
50-Day Moving Average112.91
200-Day Moving Average125.67
Relative Strength Index (RSI)61.69
Average Volume (3m)2.92M
Important Dates
Insmed upcoming earnings date is Feb 25, 2027, TBA (Confirmed).
Last Earnings DateOct 29, 2026
Next Earnings DateFeb 25, 2027
Ex-Dividend Date―
Financial Position
Insmed as a current ratio of 3.83, with Debt / Equity ratio of 102.06%
Current Ratio3.83
Quick Ratio3.54
Debt to Market Cap0.02
Net Debt to EBITDA-0.22
Interest Coverage Ratio-14.04
Taxes
In the past 12 months, Insmed has paid 5.03M in taxes.
Income Tax5.03M
Effective Tax Rate>-0.01
Enterprise Valuation
Insmed EV to EBITDA ratio is -31.96, with an EV/FCF ratio of -38.69.
EV to Sales61.74
EV to EBITDA-31.96
EV to Free Cash Flow-38.69
EV to Operating Cash Flow-40.04
Balance Sheet
Insmed has $1.15B in cash and marketable securities with $741.17M in debt, giving a net cash position of $405.46M billion.
Cash & Marketable Securities$1.15B
Total Debt$741.17M
Net Cash$405.46M
Net Cash Per Share$1.86
Tangible Book Value Per Share$2.36
Margins
Gross margin is 84.26%, with operating margin of -194.04%, and net profit margin of -210.54%.
Gross Margin84.26%
Operating Margin-194.04%
Pretax Margin-209.71%
Net Profit Margin-210.54%
EBITDA Margin-193.18%
EBIT Margin-195.90%
Analyst Forecast
The average price target for Insmed is $194.63, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$194.63
Price Target Upside57.10% Upside
Analyst ConsensusStrong Buy
Analyst Count21
Revenue Growth Forecast239.97%
EPS Growth Forecast54.44%